Related Experiment Video
Updated: Nov 26, 2025

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Acquired bleeding disorders through antithrombotic therapy: the implications for dental practitioners
1Dental Core Trainee 1 in Oral and Maxillofacial Surgery, Forth Valley Royal Hospital, Stirling Rd, Larbert, FK5 4WR, UK. anmar.al-ansari2@nhs.scot.
Antithrombotic medications are a common cause of acquired bleeding disorders. Dental surgeons must understand these drugs to safely manage patients undergoing procedures with bleeding risks.
Area of Science:
- Pharmacology
- Dental Surgery
- Hematology
Background:
- Antithrombotic medications are frequently prescribed for various clinical conditions.
- These drugs are a leading cause of acquired bleeding disorders.
- Oral administration is the most common route for these medications.
Purpose of the Study:
- To highlight the significance of antithrombotic medications in acquired bleeding disorders.
- To inform dental surgeons about the implications of these drugs in patient management.
- To emphasize the need for awareness regarding antithrombotic drug mechanisms and their impact on dental procedures.
Main Methods:
- Review of scientific literature on antithrombotic medications.
- Analysis of the mechanisms of action of common antithrombotic drugs.
- Evaluation of the impact of these medications on dental procedures with bleeding potential.
Main Results:
- Antithrombotic medications represent a major cause of acquired bleeding disorders.
- Understanding their pharmacological action is crucial for clinical practice.
- Dental management requires careful consideration of patients on these medications.
Conclusions:
- Dental surgeons must possess comprehensive knowledge of antithrombotic medications.
- Awareness of drug mechanisms and bleeding risks is essential for safe dental practice.
- Informed management of patients on antithrombotics minimizes complications during dental procedures.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

